This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Axceso Biopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Sung Jun Park
Introduction
Sung Jun Park is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work has led to the development of a unique compound that holds promise for medical applications.
Latest Patents
Sung Jun Park holds 1 patent for a pyrimido pyrimidinone compound and a pharmaceutical composition comprising the same. This patent discloses a compound that effectively inhibits PD-L1 expression, which is crucial in cancer therapy. The pharmaceutical composition containing this compound can be utilized for the treatment or prevention of cancer, showcasing its potential impact on healthcare.
Career Highlights
Sung Jun Park is associated with Axceso Biopharma Co., Ltd., where he continues to advance his research and development efforts. His work at this company emphasizes the importance of innovative solutions in the pharmaceutical industry.
Collaborations
Some of his coworkers include Young Jun Park and Hyebin Yoo, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Sung Jun Park's contributions to the field of pharmaceuticals, particularly through his patented compound, highlight his role as an influential inventor. His work not only advances scientific knowledge but also offers hope for effective cancer treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile